The L858R expression is a common type of EGFR mutation in lung adenocarcinoma, which related to a longer overall survival and lower tumor mutation burden value compared to EGFR wild type [45,46], but the prognosis of a L858R mutation is worse than the deletions in exon 19 phenotype [17,47,48]. This evidence concerns the gene EGFR and neoplasm.